Clinical Trials Directory

Trials / Completed

CompletedNCT01910467

Avoiding Hypotension in Preterm Neonates

Avoiding Hypotension in Preterm Neonates (AHIP) - A Randomised Controlled Study on Near Infrared Spectroscopy Monitoring of Peripheral-muscle and Cerebral Oxygenation With Defined Interventions Versus Routine Monitoring and Treatment in Preterm Neonates

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
6 Hours
Healthy volunteers
Not accepted

Summary

Objectives Firstly to examine in preterm neonates, whether it is possible to reduce number of hypotensive episodes and use of catecholamines by applying cerebral/peripheral near infrared spectroscopy in combination with predefined interventions and secondly to explore the potential impact on cerebral injury and mortality. Hypothesis By using predefined interventions for changes in cerebral/peripheral oxygenation ratio investigators will reduce hypotensive episodes and use of catecholamines which will reduce cerebral injury and mortality. Methods Cerebral (cTOI) and peripheral-muscle (pTOI) tissue-oxygenation-index (NIRO 300) will be measured for 24h starting \<6 hours postpartum. When cTOI/pTOI ratio increases \>5% within a 6h period, predefined interventions will be performed. Primary outcome parameter will be duration of hypotensive episodes and use of catecholamines during the first 48h after birth. Secondary outcome parameters will be cerebral injury and mortality.

Conditions

Interventions

TypeNameDescription
DEVICENIRS visible and predefined interventionsNIRS measurements are visible and the patients will be treated according to predefined clinical interventions: If cTOI/pTOI ratio increases \>5% within a six-hours-period echocardiography will be performed and based on results of echocardiography and blood pressure a volume bolus or, if ventilated, modification of ventilation or treatment of patent ductus arteriosus will be considered.
DEVICENIRS not visible and treatment as usualNIRS not visible and the patients will be treated according to routine

Timeline

Start date
2013-11-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2013-07-29
Last updated
2017-01-18

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01910467. Inclusion in this directory is not an endorsement.